Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.

McCormick DL, Rao KV, Johnson WD, Bosland MC, Lubet RA, Steele VE.

Cancer Prev Res (Phila). 2010 Mar;3(3):381-92. doi: 10.1158/1940-6207.CAPR-09-0176. Epub 2010 Feb 9.

2.

Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone.

Rao KV, Johnson WD, Bosland MC, Lubet RA, Steele VE, Kelloff GJ, McCormick DL.

Cancer Res. 1999 Jul 1;59(13):3084-9.

3.

Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.

Ozten N, Horton L, Lasano S, Bosland MC.

Cancer Prev Res (Phila). 2010 Mar;3(3):371-80. doi: 10.1158/1940-6207.CAPR-09-0152. Epub 2010 Feb 23.

4.

Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat.

McCormick DL, Rao KV.

Eur Urol. 1999;35(5-6):464-7.

PMID:
10325506
5.

Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid.

McCormick DL, Rao KV, Steele VE, Lubet RA, Kelloff GJ, Bosland MC.

Cancer Res. 1999 Feb 1;59(3):521-4.

6.

Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats.

McCormick DL, Rao KV, Dooley L, Steele VE, Lubet RA, Kelloff GJ, Bosland MC.

Cancer Res. 1998 Aug 1;58(15):3282-8.

8.

Null effect of dietary restriction on prostate carcinogenesis in the Wistar-Unilever rat.

McCormick DL, Johnson WD, Haryu TM, Bosland MC, Lubet RA, Steele VE.

Nutr Cancer. 2007;57(2):194-200.

PMID:
17571953
9.

Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.

Waters DJ, Shen S, Kengeri SS, Chiang EC, Combs GF Jr, Morris JS, Bostwick DG.

Nutrients. 2012 Nov 6;4(11):1650-63. doi: 10.3390/nu4111650.

11.

The future of prostate cancer prevention.

Brawley OW, Barnes S, Parnes H.

Ann N Y Acad Sci. 2001 Dec;952:145-52. Review.

PMID:
11795434
12.

Prostate carcinogenesis induced by N-methyl-N-nitrosourea (mnu) in gerbils: histopathological diagnosis and potential invasiveness mediated by extracellular matrix components.

Gonçalves BF, Zanetoni C, Scarano WR, Góes RM, Vilamaior PS, Taboga SR, Campos SG.

Exp Mol Pathol. 2010 Feb;88(1):96-106. doi: 10.1016/j.yexmp.2009.09.017. Epub 2009 Oct 8.

PMID:
19818764
13.

Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.

McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VE.

Nutr Cancer. 2007;57(2):184-93.

PMID:
17571952
14.

Protective effect of γ-tocopherol-enriched diet on N-methyl-N-nitrosourea-induced epithelial dysplasia in rat ventral prostate.

Sanches LD, Santos SA, Carvalho JR, Jeronimo GD, Favaro WJ, Reis MD, Felisbino SL, Justulin LA Jr.

Int J Exp Pathol. 2013 Dec;94(6):362-72. doi: 10.1111/iep.12042. Epub 2013 Oct 29.

15.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864. Epub 2008 Dec 9.

16.

Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats.

Chen X, Mikhail SS, Ding YW, Yang Gy, Bondoc F, Yang CS.

Carcinogenesis. 2000 Aug;21(8):1531-6.

PMID:
10910955
17.

Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.

Lucia MS, Anzano MA, Slayter MV, Anver MR, Green DM, Shrader MW, Logsdon DL, Driver CL, Brown CC, Peer CW, et al.

Cancer Res. 1995 Dec 1;55(23):5621-7.

18.

Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.

Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman SM, McDonnell TJ, Lieberman R, Logothetis C, Ho SM.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1697-702.

19.

A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Dunn BK, Richmond ES, Minasian LM, Ryan AM, Ford LG.

Nutr Cancer. 2010;62(7):896-918. doi: 10.1080/01635581.2010.509833. Review.

PMID:
20924966
20.

Chemopreventive effects of zinc on prostate carcinogenesis induced by N-methyl-N-nitrosourea and testosterone in adult male Sprague-Dawley rats.

Banudevi S, Elumalai P, Arunkumar R, Senthilkumar K, Gunadharini DN, Sharmila G, Arunakaran J.

J Cancer Res Clin Oncol. 2011 Apr;137(4):677-86. doi: 10.1007/s00432-010-0926-4. Epub 2010 Jun 16.

PMID:
20552224

Supplemental Content

Support Center